Affiliations 

  • 1 The Center for Natural Products Research and Drug Discovery (CENAR), Wellness Research Cluster, University of Malaya, 50603 Kuala Lumpur, Malaysia
  • 2 Department of Biomedical Science, Faculty of Science, Lincoln University College, Malaysia
  • 3 International Islamic University Malaysia, Kuantan Campus, Malaysia
Saudi J Biol Sci, 2019 Nov;26(7):1519-1524.
PMID: 31762620 DOI: 10.1016/j.sjbs.2018.12.016

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a multi-factorial disease and the most common of chronic liver diseases worldwide. The four clinical-pathological entities which are usually followed by NAFLD course include non-alcoholic steatosis, non-alcoholic steatohepatitis, advanced fibrosis/cirrhosis, and hepatocellular carcinoma. The cornerstones of NAFLD management and treatment, however, are healthy lifestyles such as dietary modifications, regular physical activity, and gradual weight loss. At present, no drugs or pharmacological agents have been approved for long-term treatment of NAFLD. Therefore, lifestyle modification is considered the main clinical recommendation and an initial step for the management of NAFLD.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.